Cargando…

Budesonide: A promising candidate therapeutic for early COVID-19

Detalles Bibliográficos
Autores principales:	Patel, Shailesh Kumar, Kumar, Rakesh, Rana, Jigyasa, Agrawal, Aditya, Singh, Alok, Kumar, Adesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327609/ https://www.ncbi.nlm.nih.gov/pubmed/34367631 http://dx.doi.org/10.1016/j.amsu.2021.102605

Ejemplares similares

Resurgence of cholera in the COVID-19 era: a global health concern
por: Niranjan, Ankush K., et al.
Publicado: (2023)

Vitamin D in therapy and management: armor against COVID-19 – correspondence
por: Channabasappa, Nikhil K., et al.
Publicado: (2023)

Monkeypox: A global threat to domestic and wild animals – Correspondence
por: K. C, Nikhil, et al.
Publicado: (2022)

Mpox and the need for improved diagnostics – correspondence
por: Patel, Shailesh K., et al.
Publicado: (2023)

Spillover of viruses and global concern: is simian haemorrhagic fever virus next in queue? – correspondence
por: Patel, Shailesh K., et al.
Publicado: (2023)

Mpox vaccination in global perspective: priorities and challenges
por: Rana, Jigyasa, et al.
Publicado: (2023)

The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2022)

Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond
por: Dhama, Kuldeep, et al.
Publicado: (2020)

High-dose budesonide for early COVID-19
por: Berezowski, Ivan, et al.
Publicado: (2021)

Promising Antiviral Molecules from Ayurvedic Herbs and Spices against COVID-19
por: Rajan, Mariappan, et al.
Publicado: (2021)

High-dose budesonide for early COVID-19
por: Lipworth, Brian, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: Choi, Jae Chol, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: San-Juan, Rafael, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: Zeitlinger, Markus, et al.
Publicado: (2021)

MERS Vaccine Candidate Offers Promise, but Questions Remain
por: Menachery, Vineet D.
Publicado: (2015)

Early initiation of breast feeding on the rise in India
por: Aguayo, Víctor M, et al.
Publicado: (2016)

Ivermectin: potential candidate for the treatment of Covid 19
por: Gupta, Dhyuti, et al.
Publicado: (2020)

Budesonide/formoterol combination for reducing cough in COVID-19 patients—A case of inflated expectations!
por: Kaur, Onkardeep, et al.
Publicado: (2023)

Dexamethasone: A boon for critically ill COVID-19 patients?
por: Patel, Shailesh Kumar, et al.
Publicado: (2020)

Ancillary protective gears in the COVID- 19 Era
por: Jain, Divya, et al.
Publicado: (2020)

Potential therapeutic role of budesonide to reduce COVID-19 severity
por: Mohiuddin, Md, et al.
Publicado: (2022)

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma
por: Morice, A H, et al.
Publicado: (2007)

The kidney and COVID-19 patients – Important considerations
por: Patel, Shailesh Kumar, et al.
Publicado: (2020)

The role of disinfectants and sanitizers during COVID-19 pandemic: advantages and deleterious effects on humans and the environment
por: Dhama, Kuldeep, et al.
Publicado: (2021)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
por: Sharun, Khan, et al.
Publicado: (2020)

Hindrance and Possible Solutions of Conducting a Clinical Trial: A Student's Perspective
por: Balasundaram, Mahesh Kumar, et al.
Publicado: (2022)

Fulfilling the promise of digital health interventions (DHI) to promote women’s sexual, reproductive and mental health in the aftermath of COVID-19
por: Chattu, Vijay Kumar, et al.
Publicado: (2021)

High-dose budesonide for early COVID-19 – Authors' reply
por: Hobbs, F D Richard, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19 – Authors' reply
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Erratum: Origin of multiple band gap values in single width nanoribbons
por: Deepika,, et al.
Publicado: (2016)

COVID-19 and anticoagulant based therapeutics: Approach with great promise
por: Sharma, Varun Kumar, et al.
Publicado: (2021)

Origin of multiple band gap values in single width nanoribbons
por: Goyal, Deepika, et al.
Publicado: (2016)

Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools
por: Pathak, Mamta, et al.
Publicado: (2020)

Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

The promising potential of piperlongumine as an emerging therapeutics for cancer
por: Parama, Dey, et al.
Publicado: (2021)

Commentary: Significance of early screening for color vision in children
por: Singh, Atul Kumar, et al.
Publicado: (2021)

Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
por: Arun, Jenish J, et al.
Publicado: (2012)

Tocilizumab in severe COVID-19: A promise fulfilled
por: Levi, Marcel
Publicado: (2022)

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
por: Agusti, Alvar, et al.
Publicado: (2021)

Is inhaled budesonide an effective treatment for patients with mild early symptoms of COVID-19?
por: Kareemi, Hashim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i9q1hha8luo46ljp7m8hciko8p